review · Clinical Therapeutics

Evolution of Drug Development and Regulatory Affairs: The Demonstrated Power of Artificial Intelligence

202425 citationsOpen accessUniversity of Pretoria

Abstract

AI has adequately proven its utility in drug development, prompting further investigations into the translational value of its utility based on cost and time saved for the delivery of essential drugs.

Research topics

Biosimilars and Bioanalytical Methods
Biotechnology and Related Fields
Pharmaceutical Economics and Policy

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.clinthera.2024.05.012

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.